Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 462

1.

Recent advances in rilpivirine: new data and promising treatment option.

Casado JL, Bañón S.

AIDS Rev. 2014 Jul-Sep;16(3):172-81.

PMID:
25221991
[PubMed - in process]
2.

Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.

Flanagan S, Crawford-Jones A, Orkin C.

Expert Rev Clin Pharmacol. 2014 Sep 11:1-14. [Epub ahead of print]

PMID:
25209158
[PubMed - as supplied by publisher]
3.

Management of hepatitis C virus and human immunodeficiency virus coinfection.

O'neil CR, Coffin CS.

Minerva Gastroenterol Dietol. 2014 Sep;60(3):165-75.

PMID:
25176054
[PubMed - in process]
4.

Predicting the Probability of Experiencing Clinically Significant Drug-Drug Interactions Involving Boceprevir-Containing Hepatitis C Therapy Among Patients Coinfected with Hepatitis C and HIV.

Patel N, Veve M, Nasiri M, Bliss S, McNutt LA, Lazariu V, Miller C.

AIDS Patient Care STDS. 2014 Aug 5. [Epub ahead of print] No abstract available.

PMID:
25093994
[PubMed - as supplied by publisher]
5.

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir.

Sabo JP, Kort J, Ballow C, Haschke M, Battegay M, Fuhr R, Girlich B, Schobelock M, Feifel U, Lang B, Li Y, Elgadi M.

Clin Infect Dis. 2014 Aug 4. pii: ciu616. [Epub ahead of print]

PMID:
25091302
[PubMed - as supplied by publisher]
6.

A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA.

Scarborough RJ, Lévesque MV, Boudrias-Dalle E, Chute IC, Daniels SM, Ouellette RJ, Perreault JP, Gatignol A.

Mol Ther Nucleic Acids. 2014 Jul 29;3:e178. doi: 10.1038/mtna.2014.31.

PMID:
25072692
[PubMed]
Free PMC Article
7.

Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.

Sulkowski MS, Naggie S, Lalezari J, Fessel WJ, Mounzer K, Shuhart M, Luetkemeyer AF, Asmuth D, Gaggar A, Ni L, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Rodriguez-Torres M, Dieterich D; PHOTON-1 Investigators.

JAMA. 2014 Jul 23-30;312(4):353-61. doi: 10.1001/jama.2014.7734.

PMID:
25038354
[PubMed - indexed for MEDLINE]
8.

HIV-Hepatitis C Virus Co-infection in the era of Direct-Acting Antivirals.

Bichoupan K, Dieterich DT, Martel-Laferrière V.

Curr HIV/AIDS Rep. 2014 Sep;11(3):241-9. doi: 10.1007/s11904-014-0217-9.

PMID:
24996617
[PubMed - in process]
9.

Sofosbuvir for the treatment of chronic hepatitis C virus infection.

Temesgen Z, Talwani R, Rizza SA.

Drugs Today (Barc). 2014 Jun;50(6):421-34. doi: 10.1358/dot.2014.50.6.2141371.

PMID:
24983590
[PubMed - in process]
10.

Drug interactions and antiretroviral drug monitoring.

Foy M, Sperati CJ, Lucas GM, Estrella MM.

Curr HIV/AIDS Rep. 2014 Sep;11(3):212-22. doi: 10.1007/s11904-014-0212-1.

PMID:
24950731
[PubMed - in process]
11.

Hepatitis C in HIV-Infected Patients: Impact of Direct-Acting Antivirals.

Bichoupan K, Dieterich DT.

Drugs. 2014 Jun;74(9):951-61. doi: 10.1007/s40265-014-0232-6.

PMID:
24866024
[PubMed - in process]
12.

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives.

Degasperi E, Aghemo A.

Hepat Med. 2014 Apr 29;6:25-33. doi: 10.2147/HMER.S44375. eCollection 2014. Review.

PMID:
24822024
[PubMed]
Free PMC Article
13.

Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.

Mandorfer M, Payer BA, Niederecker A, Lang G, Aichelburg MC, Strassl R, Boesecke C, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T.

AIDS Patient Care STDS. 2014 May;28(5):221-7. doi: 10.1089/apc.2013.0359.

PMID:
24796757
[PubMed - indexed for MEDLINE]
14.

A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.

Colpitts CC, Schang LM.

J Virol. 2014 Jul;88(14):7806-17. doi: 10.1128/JVI.00896-14. Epub 2014 Apr 30.

PMID:
24789779
[PubMed - indexed for MEDLINE]
15.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

Grinsztejn B, De Castro N, Arnold V, Veloso VG, Morgado M, Pilotto JH, Brites C, Madruga JV, Barcellos NT, Santos BR, Vorsatz C, Fagard C, Santini-Oliveira M, Patey O, Delaugerre C, Chêne G, Molina JM; ANRS 12 180 Reflate TB study group.

Lancet Infect Dis. 2014 Jun;14(6):459-67. doi: 10.1016/S1473-3099(14)70711-X. Epub 2014 Apr 9. Erratum in: Lancet Infect Dis. 2014 Jun;14(6):448.

PMID:
24726095
[PubMed - indexed for MEDLINE]
16.

Acyclic nucleoside phosphonates: a study on cytochrome P450 gene expression.

Nekvindova J, Contreras JA, Juvan P, Fon Tacer K, Anzenbacher P, Zidek Z, Kopecna Zapletalova M, Rozman D, Anzenbacherova E.

Xenobiotica. 2014 Aug;44(8):708-15. doi: 10.3109/00498254.2014.895880. Epub 2014 Mar 5.

PMID:
24593268
[PubMed - in process]
17.

Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.

Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP.

Expert Rev Gastroenterol Hepatol. 2014 May;8(4):351-8. doi: 10.1586/17474124.2014.888949. Epub 2014 Mar 3.

PMID:
24580042
[PubMed - in process]
18.

Towards hepatitis C eradication from the HIV-infected population.

Barreiro P, Fernandez-Montero JV, de Mendoza C, Labarga P, Soriano V.

Antiviral Res. 2014 May;105:1-7. doi: 10.1016/j.antiviral.2014.02.004. Epub 2014 Feb 15.

PMID:
24534673
[PubMed - in process]
19.

The fragile relationship between hepatitis C virus and its human host.

Schooley RT.

Top Antivir Med. 2014 Jan;21(5):148-51. Review.

PMID:
24531554
[PubMed - indexed for MEDLINE]
Free Article
20.

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.

Hull M, Klein M, Shafran S, Tseng A, Giguère P, Côté P, Poliquin M, Cooper C.

Can J Infect Dis Med Microbiol. 2013 Winter;24(4):217-38. Erratum in: Can J Infect Dis Med Microbiol. 2014;24(1):63.

PMID:
24489565
[PubMed]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk